Antiviral therapies for cytomegalovirus in solid-organ transplantation

被引：6

作者：

Pescovitz, Mark D. ^{[1
]}

机构：

[1] Indiana Univ, Med Ctr, Dept Surg & Microbiol Immunol, Indianapolis, IN 46202 USA

来源：

TRANSPLANTATION | 2007年 / 84卷 / 06期

关键词：

D O I：

10.1097/01.tp.0000280538.30629.99

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S2 / S6

页数：5

共 48 条

[1] Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection [J].

Avery, RK ;

Bolwell, BJ ;

Yen-Lieberman, B ;

Lurain, N ;

Waldman, WJ ;

Longworth, DL ;

Taege, AJ ;

Mossad, SB ;

Kohn, D ;

Long, JR ;

Curtis, J ;

Kalaycio, M ;

Pohlman, B ;

Williams, JW .

BONE MARROW TRANSPLANTATION, 2004, 34 (12) :1071-1075

[2] Antiviral drugs for cytomegalovirus diseases [J].

Biron, Karen K. .

ANTIVIRAL RESEARCH, 2006, 71 (2-3) :154-163

[3] Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients [J].

Bonaros, NE ;

Kocher, A ;

Dunkler, D ;

Grimm, M ;

Zuckermann, A ;

Ankersmit, J ;

Ehrlich, M ;

Wolner, E ;

Laufer, G .

TRANSPLANTATION, 2004, 77 (06) :890-897

[4] Late cytomegalovirus disease with atypical presentation in renal transplant patients: Case reports [J].

Boobes, Y ;

Al Hakim, M ;

Dastoor, H ;

Bernieh, B ;

Abdulkhalik, S .

TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) :1841-1843

[5] Concurrent antiviral and immunosuppressive activities of leflunomide in vivo [J].

Chong, AS ;

Zeng, H ;

Knight, DA ;

Shen, J ;

Meister, GT ;

Williams, JW ;

Waldman, WJ .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) :69-75

[6] Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients [J].

Clark, BS ;

Chang, IF ;

Karpen, SJ ;

Herrera, L ;

Scott, JD ;

Bristow, LJ ;

Quirós-Tejeira, RE ;

Goss, JA .

TRANSPLANTATION, 2004, 77 (09) :1480-1480

[7] Variability in standard care for cytomegalovirus prevention and detection in pediatric lung transplantation: Survey of eight pediatric lung transplant programs [J].

Danziger-Isakov, LA ;

Faro, A ;

Sweet, S ;

Michaels, MG ;

Aurora, P ;

Mogayzel, PJ ;

Mallory, GB ;

Boyer, DM ;

Rice, TB ;

DelaMorena, M ;

DeBaun, MR .

PEDIATRIC TRANSPLANTATION, 2003, 7 (06) :469-473

[8] Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide [J].

Ehlert, K. ;

Groll, A. H. ;

Kuehn, J. ;

Vormoor, J. .

KLINISCHE PADIATRIE, 2006, 218 (03) :180-184

[9] Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporin [J].

Flechner, SM ;

Goldfarb, D ;

Modlin, C ;

Feng, JY ;

Krishnamurthi, V ;

Mastroianni, B ;

Savas, K ;

Cook, DJ ;

Novick, AC .

TRANSPLANTATION, 2002, 74 (08) :1070-1076

[10] Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients [J].

Funch, DP ;

Walker, AM ;

Schneider, G ;

Ziyadeh, NJ ;

Pescovitz, MD .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (12) :2894-2900

← 1 2 3 4 5 →